Cellectar Biosciences's total assets for Q3 2025 were $14.63M, an increase of 6.81% from the previous quarter. CLRB total liabilities were $5.25M for the fiscal quarter, a -15.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.